Skip to main content
KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
26.73
+7.49 (38.93%)
Apr 29, 2026, 9:39 AM EDT - Market open

KalVista Pharmaceuticals Revenue

In the year 2025, KalVista Pharmaceuticals had annual revenue of $73.62M. KalVista Pharmaceuticals had revenue of $59.93M in the quarter ending December 31, 2025.

Revenue (ttm)
$73.62M
Revenue Growth
n/a
P/S Ratio
13.39
Revenue / Employee
$267,698
Employees
275
Market Cap
1.37B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202573.62M--
Apr 30, 2025---
Dec 31, 2024---
Apr 30, 2024---
Apr 30, 2023---
Apr 30, 2022 Pro Pro Pro
Apr 30, 2021 Pro Pro Pro
Apr 30, 2020 Pro Pro Pro
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 2.72B
Xeris Biopharma Holdings 291.85M
Maravai LifeSciences Holdings 185.74M
Geron 183.88M
Evommune 13.00M
Inventiva 7.94M
Aktis Oncology 6.50M
Revenue Rankings

KALV News

More News